EUVIMEDEUVIMED entdecken
Open Access

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models

Patrizia Porazzi, Siena Nason, Ziqi Yang, Alberto Carturan, Guido Ghilardi, Puneeth Guruprasad, Ruchi P Patel, Melody Tan, Anushka Anant Padmanabhan, Jean Lemoine, Eugenio Fardella, Yunlin Zhang und 18 weitere

Cancer Cell · 2025-03 · 43 (3) · 537-551.e7

DOI: 10.1016/j.ccell.2025.01.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-03. Verfasst von Patrizia Porazzi und 29 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Hospital of the University o…. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Immunotherapy, Adoptive, Polycomb Repressive Complex 2, Pyridones. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Stichting Lymph&Co, Parker Institute for Cancer Immunotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinImmunotherapy, AdoptivePolycomb Repressive Complex 2PyridonesNeoplasmsT-LymphocytesHumansAnimalsMiceReceptors, Chimeric AntigenBiphenyl CompoundsCell Line, TumorXenograft Model Antitumor AssaysMorpholinesBenzamidesFemale

Stichwörter der Autor:innen

B cell lymphomaCAR-TEZH1EZH2T cell receptoradoptive T cell therapychimeric antigen receptor T cellsepigeneticsmultiple myelomasolid cancerstazemetostatvalemetostat

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanPolycomb Repressive Complex 2tazemetostatEZH1 protein, humanPyridonesReceptors, Chimeric AntigenBiphenyl CompoundsMorpholinesBenzamides

Autor:innen und Institutionen

  • Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; Lymphoma Program, Abramson Canc…
  • Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; School of Medicine, Università…
  • Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.

Förderung

  • NCI NIH HHS
  • Stichting Lymph&Co
  • Parker Institute for Cancer Immunotherapy
  • Laffey-McHugh Foundation
  • National Cancer Institute

Zitieren

APA

Porazzi, P., Nason, S., Yang, Z., Carturan, A., Ghilardi, G., Guruprasad, P., Patel, R. P., Tan, M., Padmanabhan, A. A., Lemoine, J., Fardella, E., Zhang, Y., Pajarillo, R., Chen, L., Ugwuanyi, O., Markowitz, K., Delman, D., Angelos, M. G., Shestova, O., …, & Ruella, M. (2025). EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models. Cancer Cell, 43(3), 537-551.e7. https://doi.org/10.1016/j.ccell.2025.01.013

Vancouver

Porazzi P, Nason S, Yang Z, Carturan A, Ghilardi G, Guruprasad P, et al. EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models. Cancer Cell. 2025;43(3):537-551.e7. doi:10.1016/j.ccell.2025.01.013

BibTeX
@article{Porazzi2025,
  author = {Porazzi, Patrizia and Nason, Siena and Yang, Ziqi and Carturan, Alberto and Ghilardi, Guido and Guruprasad, Puneeth and Patel, Ruchi P and Tan, Melody and Padmanabhan, Anushka Anant and Lemoine, Jean and Fardella, Eugenio and Zhang, Yunlin and Pajarillo, Raymone and Chen, Linhui and Ugwuanyi, Ositadimma and Markowitz, Kelly and Delman, Devora and Angelos, Mathew G and Shestova, Olga and Isshiki, Yusuke and Blanchard, Tatiana and Béguelin, Wendy and Melnick, Ari M and Linette, Gerald P and Beatty, Gregory L and Carreno, Beatriz M and Cohen, Ivan J and Paruzzo, Luca and Schuster, Stephen J and Ruella, Marco},
  title = {EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {3},
  pages = {537--551.e7},
  doi = {10.1016/j.ccell.2025.01.013}
}
Kostenlos starten →